Transactions

Focused on creating value for our clients

Value creation is at the heart of what we do. We have a long track record of successful transactions spanning a broad range of situations and industries. View our transactions by practice area and/or industry.
Click through to learn more about each transaction.
Filter by practice area : Sort by industry :
  • May 2022: Origin Merchant Partners Advises Think Research on its $25 million convertible loan facility
  • February 2022: Origin Merchant Partners Acts as Exclusive Financial Advisor to Trafalgar on its sale to CATC
  • August 2021: Origin Merchant Partners Advises CareRx Corp. on its Acquisition of the Long-Term Care Pharmacy Division of Medical Pharmacies Group Limited
  • June 2021: Origin Merchant Partners Advises CareRx Corp. on its acquisition of Rexall Pharmacy Group’s Long-Term Care Pharmacy Business in Ontario and Northern Alberta
  • February 2021: Origin Merchant Partners Acts as Exclusive Financial Advisor to Dapasoft Inc. on its Sale to Calian Group Ltd.
  • September 2020: Origin Merchant Partner Advises LifeSpeak on its $42 million Equity Investment
  • September 2020: Origin Merchant Partners advises Village Farms on its acquisition of the remaining stake in Pure Sunfarms from Emerald Health
  • May 2020: Origin Merchant Partners Advises Centric Health Corp. on its Acquisition of Remedy Holdings Inc and the Remedy’sRx Specialty Pharmacy Business
  • March 2020: Origin Merchant Securities Inc. Acts as Financial Advisor to Centric Health Corp. on its Senior Term Loan Financing by Crown Capital Partners Inc.
  • November 2019: Origin Merchant Partners Advises Centric Health Corp. on Recapitalization Transactions Worth $70 million
  • November 2019: Origin Merchant Securities Inc. Advises Centric Health Corp. on Recapitalization Transactions Worth $70 million
  • March 2018: Origin Merchant Securities Inc. Advises Pivot Pharmaceuticals Inc. on its Private Placement of Convertible Debentures
  • Jan 2018: Origin Merchant Partners Provides Fairness Opinion for the Executive Committee and Board of Aeterna Zentaris Inc. on its License and Assignment Agreement with Strongbridge Biopharma LLC
  • December 2012: Origin Merchant Partners Advises Addition Technology on its sale to AJL Ophthalmic, S.A.